| Catalog No. | VK539036 |
|---|
| Description | Libivirumab is a human monoclonal antibody directed against the hepatitis B virus. Libivirumab had an IC50 of 35 and 128 ng/ml in the neutralization assays based on ELISA and immunofluorescence assays. |
|---|
| Species reactivity | HepatitisBvirusgenotypeA(HBV-A) |
|---|
| Applications | Research Grade Biosimilar |
|---|
| Host species | Human |
|---|
| Isotype | IgG1, kappa |
|---|
| Expression system | Mammalian Cells |
|---|
| Clonality | Monoclonal |
|---|
| Target | Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S |
|---|
| Concentration | 2.4mg/ml |
|---|
| Endotoxin level | Please contact the lab for this information. |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G, purified from cell culture supernatant. |
|---|
| Accession | P03142 |
|---|
| Form | Liquid |
|---|
| Storage buffer | 0.01M PBS,pH7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -479°C. |
|---|
| Alternate Names | 17.1.41,HepeX-B(combinationofexbivirumabandlibivirumab),CAS:569658-79-3 |
|---|
| Background | Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively. |
|---|
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|---|
